Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes

@article{Saver2021StandardizedNF,
  title={Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes},
  author={Jeffrey L. Saver and Napasri N. Chaisinanunkul and Bruce C.V. Campbell and James Charles Grotta and Michael D. Hill and Pooja Khatri and Jaren W. Landen and Maarten G. Lansberg and Chitra Venkatasubramanian and Gregory W. Albers},
  journal={Stroke},
  year={2021},
  volume={52},
  pages={3054 - 3062}
}
Supplemental Digital Content is available in the text. The modified Rankin Scale (mRS), a 7-level, clinician-reported, measure of global disability, is the most widely employed outcome scale in acute stroke trials. The scale’s original development preceded the advent of modern clinimetrics, but substantial subsequent work has been performed to enable the mRS to meet robust contemporary scale standards. Prior research and consensus recommendations have focused on modernizing 2 aspects of the mRS… 

Figures and Tables from this paper

Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysis.
TLDR
MSU use was associated with an approximately 65% increase in the odds of excellent outcome and a 30-minute reduction in onset-to-IVT times, without safety concerns, which should help guideline writing committees and policy makers.
European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
Six randomized controlled clinical trials have assessed whether mechanical thrombectomy (MT) alone is non-inferior to intravenous thrombolysis (IVT) plus MT within 4.5 hours of symptom onset in
Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke
TLDR
Analysis of evidence from nonrandomized studies suggests that tenecteplase is as safe as alteplase for the treatment of AIS andTenecte Plase is potentially associated with more favorable outcomes.
European Stroke Organisation (ESO) guidelines on mobile stroke units for prehospital stroke management
TLDR
This European Stroke Organisation (ESO) guideline provides an up-to-date evidence-based recommendation to assist decision-makers in their choice on using MSUs for prehospital management of suspected stroke, which includes patients with acute ischaemic stroke (AIS), intracranial haemorrhage (ICH) and stroke mimics.
European Stroke Organisation – European Society for Minimally Invasive Neurological Therapy expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stroke and anterior circulation large vessel occlusion
Six randomized controlled clinical trials have assessed whether mechanical thrombectomy (MT) alone is non-inferior to intravenous thrombolysis (IVT) plus MT within 4.5 hours of symptom onset in
Systematic Review - Combining Neuroprotection With Reperfusion in Acute Ischemic Stroke
TLDR
Future neuroprotection studies should report standardized functional outcome measures and combine neuroprotective agents with reperfusion therapies in AIS or aim to include prespecified subgroup analyses for treatment with IVT and/or EVT.
Prevalence and Significance of Impaired Microvascular Tissue Reperfusion Despite Macrovascular Angiographic Reperfusion (No-Reflow)
TLDR
Cerebral no-reflow in humans is common, can be detected by its characteristic perfusion imaging profile using readily available sequences in the clinical setting, and is associated with posttreatment complications and being dependent or dead at 90 days.
Integrated Care for Stroke Management: Easy as ABC.
No Abstract.

References

SHOWING 1-10 OF 44 REFERENCES
Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis
TLDR
The reported data support the view that the modified Rankin scale is a valuable instrument for assessing the impact of new stroke treatments, and patient comorbidities and socioeconomic factors should be considered in properly applying and interpreting the mRS.
Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.
TLDR
The 7-level, modified Rankin Scale (mRS) has several major strengths: it covers the entire range of functional outcomes from no symptoms to death, its categories are intuitive and easily grasped by both clinicians and patients, its concurrent validity is demonstrated by strong correlation with measures of stroke pathology and agreement with other stroke scales, and its use has demarcated effective and ineffective acute stroke therapies in trials with appropriately powered sample sizes.
Variability in Modified Rankin Scoring Across a Large Cohort of International Observers
TLDR
Interobserver variability in mRS assessment is confirmed, and the heterogeneity across countries is intriguing because it appears not to be related solely to language.
Improving the Reliability of Stroke Disability Grading in Clinical Trials and Clinical Practice: The Rankin Focused Assessment (RFA)
TLDR
The Rankin Focused Assessment yields high interrater reliability in the grading of final global disability among consecutive patients with stroke participating in a randomized clinical trial.
Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale
TLDR
A utility-weighted mRS performs similar to the standard ordinal mRS in detecting treatment effects in actual stroke trials and ensures the quantitative outcome is a valid reflection of patient-centered benefits.
Initial Experience of a Digital Training Resource for Modified Rankin Scale Assessment in Clinical Trials
TLDR
Certification results suggest that use of the mRS training resource can improve mRS grading, and outline the development of a video-based training package, including technical issues, patient selection procedures, and methods of scoring and assessment.
Improving Modified Rankin Scale Assessment With a Simplified Questionnaire
TLDR
The modified Rankin Scale questionnaire (smRSq) appears to have very good reliability that is similar to that of a structured interview mRS and is considerably less time-consuming.
Simple and reliable determination of the modified rankin scale score in neurosurgical and neurological patients: the mRS-9Q.
TLDR
The mRS-9Q is a simple, easy-to-administer survey with a custom Web-based mRS calculation and error-checking tool that can reliably determine the mRS by hard copy survey or by telephone and can be administered by experts or nonmedical study personnel.
Improving the Assessment of Outcomes in Stroke: Use of a Structured Interview to Assign Grades on the Modified Rankin Scale
TLDR
Variability and bias between raters in assigning patients to Rankin grades may be reduced by use of a structured interview, which could potentially improve the quality of results from clinical studies in stroke.
Determining the cut-off score for the Modified Barthel Index and the Modified Rankin Scale for assessment of functional independence and residual disability after stroke
Assessment of functional independence and residual disability is very important for measuring treatment outcome after stroke. The modified Rankin Scale (mRS) and the modified Barthel Index (MBI) are
...
...